ZNF644: Potential Drug Target Or Biomarker for Various Diseases
ZNF644: Potential Drug Target Or Biomarker for Various Diseases
ZNF644 (OTTHUMP00000011766) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the ZNF6 family, which is known for its role in regulating gene expression and cell signaling. ZNF644 has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The ZNF6 family of proteins was first identified in the 1990s by researchers who noticed that many diseases, including neurodevelopmental and psychiatric disorders, were associated with changes in the levels of certain genes. These genes were found to be expressed in the ZNF6 family, which led to the conclusion that ZNF644 and its downstream targets were involved in the regulation of cellular processes that were implicated in the development of these diseases.
Since its identification, ZNF644 has been shown to be involved in a wide range of cellular processes, including cell growth, differentiation, migration, and survival. It has been shown to play a role in the regulation of stem cell proliferation, and has been shown to be involved in the development and maintenance of neural stem cells. It has also been shown to play a role in the regulation of inflammation, and has been shown to be involved in the development of autoimmune disorders.
In addition to its potential role in disease, ZNF644 has also been shown to be a potential drug target. Several studies have shown that inhibiting the activity of ZNF644 has the potential to treat a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that inhibiting the activity of ZNF644 has the potential to treat neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, by reducing the production of toxic protein aggregates that are thought to contribute to the development of these diseases.
In addition to its potential therapeutic applications, ZNF644 has also been shown to be a valuable biomarker for the diagnosis and prognosis of various diseases. Studies have shown that the levels of ZNF644 are often reduced in the brains of individuals with neurodegenerative diseases, and that these levels are associated with poor prognosis. Similarly, studies have shown that the levels of ZNF644 are often elevated in the blood of individuals with cancer, and that these levels are associated with poor prognosis.
Overall, ZNF644 is a protein that has the potential to be a drug target or biomarker for a wide range of diseases. Further research is needed to fully understand its role in cellular processes and its potential therapeutic applications.
Protein Name: Zinc Finger Protein 644
Functions: May be involved in transcriptional regulation
More Common Targets
ZNF646 | ZNF648 | ZNF649 | ZNF652 | ZNF652-AS1 | ZNF653 | ZNF654 | ZNF655 | ZNF658 | ZNF658B | ZNF66 | ZNF660 | ZNF662 | ZNF663P | ZNF664 | ZNF664-RFLNA | ZNF665 | ZNF667 | ZNF667-AS1 | ZNF668 | ZNF669 | ZNF670 | ZNF670-ZNF695 | ZNF671 | ZNF672 | ZNF674 | ZNF674-AS1 | ZNF675 | ZNF676 | ZNF677 | ZNF678 | ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766